版本:
中国

BRIEF-TG Therapeutics announces positive DSMB recommendation

Nov 22 TG Therapeutics Inc :

* TG Therapeutics announces positive DSMB recommendation for continuation of the UNITY-CLL phase 3 trial

* Still targeting completion of enrollment in first half of 2018

* TG Therapeutics announces positive DSMB recommendation for continuation of the UNITY-CLL phase 3 trial Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐